Related Experiment Video

Updated: May 28, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Dysregulation of microRNAs in adrenocortical tumors

Puneet Singh1, Patsy S H Soon, Jean-Jacques Feige

  • 1Cancer Genetics Unit, Hormones & Cancer Group, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia. puneetsingh@sydney.edu.au

Molecular and Cellular Endocrinology
|October 15, 2011
PubMed

Insights

MicroRNAs regulate cellular processes and are implicated in cancer. This review explores microRNAs in adrenocortical tumors, highlighting their potential for diagnosis and prognosis.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • MicroRNAs (miRNAs) are key epigenetic regulators of cellular processes.
  • Deregulation of specific miRNAs is linked to various malignancies.
  • Adrenocortical tumors, including adrenocortical adenomas (ACAs) and adrenocortical cancers (ACCs), exhibit distinct miRNA expression profiles.

Purpose of the Study:

  • To review the current understanding of microRNAs in adrenocortical tumors.
  • To explore the potential of miRNAs in differentiating between ACCs and ACAs.
  • To assess the role of miRNAs in risk stratification and prognosis of adrenocortical cancer.

Main Methods:

  • Literature review of studies on microRNAs in adrenocortical tumors.
  • Analysis of miRNA expression patterns in ACCs and ACAs.
  • Evaluation of the diagnostic and prognostic implications of miRNA alterations.

Main Results:

  • Specific miRNA signatures are associated with adrenocortical adenomas and carcinomas.
  • MicroRNA expression levels can help distinguish between benign adenomas and malignant cancers.
  • Certain miRNAs correlate with disease-specific survival in adrenocortical cancer patients.

Conclusions:

  • MicroRNAs represent promising biomarkers for adrenocortical tumor diagnosis and subtyping.
  • miRNA profiling can aid in risk stratification and predicting prognosis in adrenocortical cancer.
  • Further research into miRNA mechanisms may improve adrenocortical cancer management.

More Related Videos

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics08:11

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics

Published on: March 26, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...